25I-NB4OMe
Overview[edit | edit source]
25I-NB4OMe is a synthetic psychedelic compound that belongs to the NBOMe class of drugs. It is a derivative of the phenethylamine 2C-I and is known for its potent hallucinogenic effects. The compound is primarily used in research settings and has gained attention for its psychoactive properties.
Chemical Structure[edit | edit source]
25I-NB4OMe is chemically related to 2C-I, with the addition of a methoxy group at the 4-position of the benzyl ring. This modification enhances its affinity for the serotonin receptors, particularly the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects.
Pharmacology[edit | edit source]
25I-NB4OMe acts as a potent agonist at the 5-HT2A receptor, similar to other compounds in the NBOMe series. This receptor is a subtype of the serotonin receptor and plays a crucial role in the modulation of mood, perception, and cognition. The activation of 5-HT2A receptors by 25I-NB4OMe leads to altered sensory perception and hallucinations.
Effects[edit | edit source]
The effects of 25I-NB4OMe are similar to those of other psychedelic substances, such as LSD and psilocybin. Users report visual and auditory hallucinations, altered sense of time, and changes in thought patterns. The onset of effects typically occurs within 30 to 90 minutes after ingestion, with a duration of action lasting 6 to 10 hours.
Risks and Safety[edit | edit source]
25I-NB4OMe is associated with several risks, particularly when used recreationally. Due to its potency, there is a high risk of overdose, which can lead to severe adverse effects such as tachycardia, hypertension, seizures, and psychosis. The compound has been linked to several fatalities, underscoring the importance of caution and regulation.
Legal Status[edit | edit source]
The legal status of 25I-NB4OMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Researchers must obtain special licenses to study the compound in a laboratory setting.
Related Compounds[edit | edit source]
See Also[edit | edit source]
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
